Published : 21 May, 2024
CAR T-cell therapy, a groundbreaking immunotherapy, achieved durable remission for Hamza Khan, who battled relapsed follicular lymphoma after failed conventional treatments. Initiated at Narayana Health City in September 2022, this therapy modifies a patient’s immune cells to target cancer effectively. Dr. Sharat Damodar from Narayana Health City highlighted its transformative impact in cancer treatment. Dr. Vipul Sheth of RGCIRC underscored its potential as a “living drug” for refractory cancers resistant to standard therapies like chemotherapy and transplants.
As a society, RGCIRC is looking forward to get support from generous people
Read More
It is a fact that there are absolutely no substitutes to replace human bloo...
Read More
Volunteers play an important role in today’s hospitals. They help the hos...
Read MoreRajiv Gandhi Cancer Institute and Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.
Sir Chotu Ram Marg, Sector - 5, Rohini Industrial Area, Rohini, New Delhi - 110085, India | +91-11-47022222 OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday) Emergency Services: 24x7 All weekdays
Squadron Leader Mahendra Kumar Jain Marg, Block K, Niti Bagh, New Delhi - 110049 | +91-11-45822222 OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday) Emergency Services: 24x7 All Weekdays
DONATE